Cargando…
Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational Study
Western guidelines recommend the use of intravenous iron supplementation for hemodialysis patients. However, in Japanese patients with well-controlled inflammation, iron replacement may be achieved with oral iron supplementation. This study involved 108 courses in 77 outpatient hemodialysis patients...
Autores principales: | Ogawa, Chie, Tsuchiya, Ken, Kanemitsu, Mineko, Maeda, Kunimi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824721/ https://www.ncbi.nlm.nih.gov/pubmed/36615783 http://dx.doi.org/10.3390/nu15010125 |
Ejemplares similares
-
High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational study
por: Ogawa, Chie, et al.
Publicado: (2020) -
A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients
por: Ogawa, Chie, et al.
Publicado: (2020) -
Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study
por: Ogawa, Chie, et al.
Publicado: (2017) -
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
por: Ogawa, Chie, et al.
Publicado: (2023) -
Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa
por: Ogawa, Chie, et al.
Publicado: (2021)